ILD medications: immunosuppressive drugs

ILD_IMMUNOSUPPRESSIVE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04A

21960

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

19299

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

19299

diagram downward connector

Include endpoints None

19299

diagram downward connector
ILD_IMMUNOSUPPRESSIVE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 18666 11432 7234
Unadjusted prevalence (%) 6.05 6.59 5.36
Mean age at first event (years) 50.27 49.43 51.60

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 2.69 [2.12, 3.40] 2.0e-16 943
15 years 0.01 1.73 [1.37, 2.19] 5.0e-6 499
5 years 0.00 3.43 [2.82, 4.18] 1.2e-34 301
1 year 0.00 4.00 [2.99, 5.35] 1.3e-20 66

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ILD_IMMUNOSUPPRESSIVE – ILD medications: immunosuppressive drugs
GWS hits:

Survival analyses between endpoints

Plot

before ILD medications: immunosuppressive drugs
after ILD medications: immunosuppressive drugs

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after ILD medications: immunosuppressive drugs